Kestra Medical Technologies (KMTS) Gains from Investment Securities (2025 - 2026)
Kestra Medical Technologies (KMTS) posted quarterly Gains from Investment Securities of -$376000.0 for Q2 2026, down 62.07% quarter-over-quarter from -$232000.0 in Q1 2026.
Kestra Medical Technologies (KMTS) Gains from Investment Securities (2025 - 2026) Analysis & Trends
Kestra Medical Technologies (KMTS) has reported Gains from Investment Securities for 2 consecutive years, with -$376000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Gains from Investment Securities changed N/A year-over-year to -$376000.0; the TTM figure through Apr 2026 stood at -$2.7 million (changed N/A YoY), while the FY2026 annual figure was -$2.7 million, down 200.94% from the prior year.
- Gains from Investment Securities fell to -$376000.0 in Q2 2026 per KMTS's latest filing, from -$232000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $844000.0 in Q4 2025 and bottomed at -$2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Kestra Medical Technologies | 1.45 Bn | 1.10 Bn | 15.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -376,000.00 |
| Apr 30, 2026 | -376,000.00 |
| Jan 31, 2026 | -232,000.00 |
| Jan 31, 2026 | -232,000.00 |
| Oct 31, 2025 | 844,000.00 |
| Oct 31, 2025 | 844,000.00 |
| Jul 31, 2025 | -2.91 Mn |
| Jul 31, 2025 | -2.91 Mn |